Company Name:AbbVie, Inc.
CEO: Richard A. Gonzalez

Sector: Health Technology

Exchange: New York Stock Exchange

Country: US

Description: AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.


Key numbers

Market Capitalization:170964603400
Shares Outstanding: 1762340000
Float: 1760288636
Next Earning Date:2020-07-31
TTm EPS: 5.6688
TTm Dividend Rate: 4.5
200 days moving average:87.23
50 days moving average: 95.74
One day percent Change: -1.18



2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,